Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Urges Stronger Labeling For Hydrogen Peroxide-Based Contact Lens Solutions

Executive Summary

New draft guidance from the US agency calls for manufacturers to add more information about potential risks to the labeling of some types of contact lens solution.

You may also be interested in...



Global Medtech Guidance Tracker: August 2022

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-three documents have been posted on the tracker since its last update.

FDA Advisors Consider Peroxide Risk From Contact Lens Solution

FDA advisory panel members found few easy solutions to the risk posed by contact lens solutions containing hydrogen peroxide, but agreed clearer and more consistent labeling is needed.

Durbin Lights Supplement MPL Flare In US Senate

Senate votes down Illinois Democrat’s proposal to amend stopgap appropriations bill with language calling for establishing mandatory products listing program in FDA. But proposal to give FDA MPL authority likely will return in Congress, says Natural Products Association.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel